Updates in Papular Urticaria Causes, Diagnosis, And Management: A Systematic Review

Life Sciences-Medicine

Authors

  • Mohammed Olaythah Alraddadi Consultant of Dermatology and Cosmetic Dermatology, Faculty of Medicine, University of Tabuk, KSA
  • Norah Saad M Alnawmasi Medical Intern, Tabuk University, Saudi Arabia
  • Waleed Farhan D Alshammari Medical Intern, Tabuk University, Saudi Arabia
  • Razan Kamel A Albalawi Medical Intern, Tabuk University, Saudi Arabia
  • Asma Hussain A Hamdi Medical Intern, Najran University, Saudi Arabia
  • Aedah Ahmad Alqrid Ahmad Medical student, Tabuk University, Saudi Arabia
  • Amjad Bader S Almutairi Medical student, Tabuk University, Saudi Arabia
  • Samaher Suliman Aljammaz Medical student, Tabuk University, Saudi Arabia
  • Sarah Abdulkarim M Alatawi Medical student, Tabuk University, Saudi Arabia
  • Lubna Ibrahim H Alomari Medical student, Tabuk University, Saudi Arabia
  • Shahad Faiz S Aljohani Medical student, Tabuk University, Saudi Arabia

DOI:

https://doi.org/10.22376/ijlpr.2023.13.1.SP2.L57-L65

Keywords:

Papular Urticaria, Causes of Papular Urticaria, Diagnosis of Papular Urticaria, Management of Papular Urticaria, Systematic Review

Abstract

Abstract: Papular urticaria is a frequent disturbing disease characterized by chronic or recurrent papules that are a hypersensitive reaction to mosquito, bedbug, flea, and other insect bites. PubMed, Web of Science, Science Direct, EBSCO, and Cochrane library were searched. Study articles were screened by title and abstract using Rayyan QCRI then a full-text assessment was implemented. This review investigates the published literature regarding the causes, diagnosis, and management of papular urticaria. Eight studies were included, with 527 patients with papular urticaria. Most cases were diagnosed morphologically and clinically, and only one study depended on light and electron microscopy. Arthropods and hypersensitivity reactions were the most common causes. This review reported the frequency of hypersensitivity reactions to insect bites, flea bites, bedbug bites, and domestic urticaria bites. According to reports, morphological patterns were used to diagnose most cases clinically. Insect repellents, antihistamines, antipruritic, topical steroids, and symptomatic treatments were used to treat the majority of patients with papular urticaria. 

References

Steen CJ, Carbonaro PA, Schwartz RA. Arthropods in dermatology. J Am Acad Dermatol. 2004;50(6):819-842l. doi: 10.1016/j.jaad.2003.12.019, PMID 15153881.

Ruiz-Maldonado R, Tamayo Sánchez L, Velázquez E. Epidemiology of skin diseases in 10,000 patients of pediatric age. Bol Med Hosp Infant Mex. 1977;34(1):137-61. PMID 836712.

Demain JG. Papular urticaria and things that bite in the night. Curr Allergy Asthma Rep. 2003;3(4):291-303. doi: 10.1007/s11882-003-0089-3, PMID 12791206.

Cuéllar A, García E, Rodríguez A, Halpert E, Gómez A. Functional dysregulation of dendritic cells in patients with papular urticaria caused by fleabite. Arch Dermatol. 2007;143(11):1415-9. doi: 10.1001/archderm.143.11.1415, PMID 18025366.

Burgess IF. Papular urticaria. Harper’s Textbook Pediatr Dermatol. 2011;1:71-1.

Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. Treatment of skin disease e-book: comprehensive therapeutic strategies. Elsevier Health Sciences; 2013.

Habif TP, Chapman MS, Dinulos JG, Zug KA. Skin disease e-book: diagnosis and treatment. Elsevier Health Sciences; 2017.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016 Dec;5(1):210. doi: 10.1186/s13643-016-0384-4, PMID 27919275.

Jüni P, Loke Y, Pigott T, Ramsay C, Regidor D, Rothstein H et al. Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance. Br Med J. 2016.

Chagoya RC, Hernández-Romero J, Velasco-Medina AA, Velázquez-Sámano G. Pilot study: specific immunotherapy in patients with Papular urticaria by Cimex lectularius. Eur Ann Allergy Clin Immunol. 2021.

Ahmed N, El-Kady A, Abd Elmaged W, Almatary A. Dermanyssus gallinae (Acari: Dermanyssidae) a cause of recurrent papular urticaria diagnosed by light and electron microscopy. Parasitologists U J. 2018;11(2):112-8. doi: 10.21608/PUJ.2018.16320.

Dominguez-Amorocho O, Duarte S, Garcia E, Halpert E, Cuellar A, Rodriguez A. Differences in IgE mediated basophil degranulation induced by proteic fractions from whole flea body extract in patients with papular urticaria by flea bite and healthy controls. World Allergy Organ J. 2013;6(1):10. doi: 10.1186/1939-4551-6-10, PMID 23680530.

Dominguez-Amorocho O, Duarte S, González JM, Halpert E, Ortega MC, Rodríguez A et al. Differences in systemic and skin migrating-specific CD4+ T cells in papular urticaria by flea bite. Int Arch Allergy Immunol. 2013;160(2):165-72. doi: 10.1159/000339743, PMID 23018588.

Cuéllar A, Rodríguez A, Halpert E, Rojas F, Gómez A, Rojas A et al. Specific pattern of flea antigen recognition by IgG subclass and IgE during the progression of papular urticaria caused by flea bite. Allergol Immunopathol (Madr). 2010;38(4):197-202. doi: 10.1016/j.aller.2009.09.012, PMID 20227159.

Raza N, Lodhi MS, Ahmed S, Dar NR, Ali L. Clinical study of papular urticaria. J Coll Physicians Surg Pak. 2008;18(3):147-50. PMID 18460241.

García E, Halpert E, Rodríguez A, Andrade R, Fiorentino S, García C. Immune and histopathologic examination of flea bite—induced papular urticaria. Ann Allergy Asthma Immunol. 2004;92(4):446-52. doi: 10.1016/S1081-1206(10)61781-4, PMID 15104197.

Jordaan HF, Schneider JW. Papular urticaria: a histopathologic study of 30 patients. Am J Dermatopathol. 1997;19(2):119-26. doi: 10.1097/00000372-199704000-00004, PMID 9129695.

Paller AS, Mancini AJ. Papulosquamous and related disorders. Hurwitz clinical pediatric dermatology. A Textbook of Skin Disorders of Childhood and Adolescence. 2016;3:85-106.

risafulli G, Franceschini F, Caimmi S, et al. Mild cutaneous reactionsto drugs.Acta Biomed. 2019;90(3-S):36-43. https://doi.org/10.23750/abm.v90i3-S.8159.

recalcati S. Cutaneous manifestations in COVID-19: a first perspec-tive.J Eur Acad Dermatol Venereol. 2020;34(5):e212-e213. https://doi.org/10.1111/jdv.16387.

phan T. Novel coronavirus: from discovery to clinical diagnostics.InfectGenetEvol. 2020;79:104211. https://doi.org/10.1016/j.meegid.2020.104211.

Srivastava P, Badhwar S, Chandran DS, Jaryal AK, Jyotsna VP,Deepak KK. Imbalance between angiotensin II - angiotensin (1-7) sys-tem is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension.DiabetesMetab Syndr. 2019;13(3):2061-2068. https://doi.org/10.1016/j.dsx.2019.04.042.

Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters inpatients with COVID-19 infection.Am J Hematol. 2020;95(6):E131-E134. https://doi.org/10.1002/ajh.25774.

Shagdarsuren E, Wellner M, Braesen JH, et al. Complement activationin angiotensin II-induced organ damage.Circ Res. 2005;97(7):716-724. https://doi.org/10.1161/01.RES.0000182677.89816.38.

Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China.Clin12 of 13ABUELGASIMET AL. Infect Dis. 2020;71(15):762-768. https://doi.org/10.1093/cid/ciaa248.

aymond M, Ching-A-Sue G, Van Hecke O. Mast cell stabilizers, leu-kotriene antagonists and antihistamines: a rapid review of the evidence for their use in COVID-19.CEBM. 2020. https://www.cebm.net/covid-19/mast-cell-stabilisers-leukotriene-antagonists-and-antihistamines-a-rapid-review-of-effectiveness-in-covid-19/.

McGonagle D, Sharif K, O'Regan A, Bridgewood C. The role of cyto-kines including Interleukin-6 in COVID-19 induced pneumonia andmacrophage activation syndrome-like disease.Autoimmun Rev. 2020;19(6):102537. https://doi.org/10.1016/j.autrev.2020.102537.

Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvas-cular injury and thrombosis in the pathogenesis of severe COVID-19infection: A report of five cases.Transl Res. 2020;220:1-13. https://doi.org/10.1016/j.trsl.2020.04.007.

Dastoli S, Bennardo L, Patruno C, Nisticò SP. Are erythemamultiforme and urticaria related to a better outcome of COVID-19?DermatolTher. 2020;33:e13681. https://doi.org/10.1111/dth.13681.

Jimenez-Cauhe J, Ortega-Quijano D, Suarez-Valle A, Dominguez-Santas M, Diaz-Guimaraens B, Fernandez-Nieto D. Comment on "areerythema multiforme and urticaria related to a better outcome ofCOVID 19?" eosinophil count in seven patients with COVID-19 andurticarial rash.Dermatol Ther. 2020;e13844. https://doi.org/10.1111/dth.13844.

Skroza N, Bernardini N, Balduzzi V, et al. A late-onset widespread skinrash in a previous COVID-19-infected patient: viral or multidrugeffect?J Eur Acad Dermatol Venereol. 2020. https://doi.org/10.1111/jdv.16633.

Sakaida T, Tanimoto I, Matsubara A, Nakamura M, Morita A. Uniqueskin manifestations of COVID-19: is drug eruption specific to COVID-19?J Dermatol Sci. 2020;99(1):62-64. https://doi.org/10.1016/j.jdermsci.2020.05.002.

Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P,Llamas-Velasco M. Urticaria-like lesions in COVID-19 patients arenot really urticaria—a case with clinicopathological correlation.J EurAcad Dermatol Venereol. 2020. https://doi.org/10.1111/jdv.16618.

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G,Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J. Comment on:cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.J Eur Acad DermatolVenereol. 2020;34(6):e252-e254. https://doi.org/10.1111/jdv.16470.

Upperman JS, Pillage G, Siddiqi MQ, et al. Dominance of high-producing interleukin 6 and low-producing interleukin 10 and inter-feron gamma alleles in glucose-6-phosphate dehydrogenase-deficienttrauma patients.Shock. 2005;23(3):197-201.

Dressler C, Rosumeck S, Werner RN, et al. Executive summary of themethods report for 'The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and Management of Urticaria.The 2017 revision and update.Allergy. 2018;73(5):1145-146.https://doi.org/10.1111/all.13414.

Kaushik A, Parsad D, Kumaran M. Urticaria in the times of COVID -19.Dermatologic Therapy. 2020; http://dx.doi.org/10.1111/dth.13817

reiwe J, Bernstein JA. Approach to the patient with hives.Med ClinNorth Am. 2020;104(1):15-24. https://doi.org/10.1016/j.mcna.2019.08.010.

Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospectivenationwide consensus study in Spain with 375 cases.Br J Dermatol.2020;183(1):71-77. https://doi.org/10.1111/bjd.19163.

Published

2022-12-31

How to Cite

Olaythah Alraddadi, M., Saad M Alnawmasi, N., Farhan D Alshammari, W., Kamel A Albalawi, R., Hussain A Hamdi, A., Ahmad Alqrid Ahmad, A., Bader S Almutairi, A., Suliman Aljammaz, S., Abdulkarim M Alatawi, S., Ibrahim H Alomari, L., & Faiz S Aljohani, S. (2022). Updates in Papular Urticaria Causes, Diagnosis, And Management: A Systematic Review: Life Sciences-Medicine. International Journal of Life Science and Pharma Research, 13(SP2), L57-L65. https://doi.org/10.22376/ijlpr.2023.13.1.SP2.L57-L65

Issue

Volume 13, Special Issue 2, 2023

Section

Research Articles

Copyright (c) 2022 Mohammed Olaythah Alraddadi, Norah Saad M Alnawmasi, Waleed Farhan D Alshammari, Razan Kamel A Albalawi, Asma Hussain A Hamdi, Aedah Ahmad Alqrid Ahmad, Amjad Bader S Almutairi, Samaher Suliman Aljammaz, Sarah Abdulkarim M Alatawi, Lubna Ibrahim H Alomari, Shahad Faiz S Aljohani

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.